@NCIJBSloan 2 years ago
#WomeninSTEM! Don’t overlook the opportunities in the #DataScience field. Whatever your interests—molecular biology, genetics, epidemiology, clinical, medications development, computer technology—this field has a place for you. Read my blog to learn more! https://datascience.cancer.gov/news-events/blog/women-data-science-interview-dr-jill-barnholtz-sloan https://t.co/eX8flLhFhr
@Montreal_AI 2 years ago
Read, Attend, and Code: Pushing the Limits of Medical Codes Prediction from Clinical Notes by Machines Byung-Hak Kim, Varun Ganapathi : https://arxiv.org/abs/2107.10650 #ArtificialIntelligence #MachineLearning #Healthcare https://t.co/aEK0bwa91Q
@KU_ENT 2 years ago
Read about our cutting edge research leveraging #machinelearning to analyze complex data for clinical apps 🤓🧠 @drandresbur & @JenVillwockMD featured in Kansas Science + Medicine @KUMedCenter https://bit.ly/KUMedmagazine #ENTsurgery #WeAreOto #AugmentedIntelligence #MedTwitter https://t.co/ea8roT0ivo
@SanjeevBhavnani 4 years ago
Looking for pediatric cardiologists to read 8-second single lead ECG rhythm strips for collaboration on an #AI #MachineLearning #DigitalHealth clinical trial Requirements 1. Board certified 2. Active medical license Can Read ECGs online, phone, tablet DM if interested!
@techcrunch.com 6 years ago
GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market
@mashable.com 7 years ago
Severe burns can heal faster with this 3-D skin printer
@techcrunch.com 8 years ago
AiCure Raises $12.25 Million For Its Treatment Monitoring Technology
@techcrunch.com 8 years ago
TrialMatch Aims To Ease The Pain Of Clinical Trials Recruitment
@techcrunch.com 8 years ago
Israel Could Grow Into A Global Cannabis Startup Superpower
@techcrunch.com 8 years ago
Google’s New Health Wearable Delivers Constant Patient Monitoring
@techcrunch.com 9 years ago
TrialReach Raises $13.5M Series B To Match Patients To Clinical Trials
@techcrunch.com 9 years ago
Amid ‘Right To Try’ Debate, myTomorrows Raises €4.5M To Give Patients Access To Development-Stage Drugs